Zhao B, Qi H, Wu J, Ma W, et al. Cemiplimab Plus Chemotherapy Could Be a First-Line Option for Advanced and Metastatic NSCLC: Results From the Phase 3 EMPOWER-Lung 3 Part 2 Trial. J Thorac Oncol 2023;18:e72-e73.
PMID: 37348996